Two top immunologists agree with recent Nature paper, linked to in this article, finding that the monoclonal antibody cocktail ZMapp is the most effective anti-Ebola drug yet. US HSS has set aside $24 million to accelerate production, it announced last week. But two vaccines, one developed by the NIH, are also on the way. See the article "ZMapp: Best Anti-Ebola Drug Yet" in Drug Discovery & Development online.